A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)
Clinical trial NCT03740724 · TERMINATED
Trial details
- NCT number
- NCT03740724
- Sponsor
- Castle Creek Biosciences, LLC.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-18
- Primary completion
- 2020-09-23
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.